Pfizer — Earning Quality
EARNING QUALITY TICKER: [US.PFE - Pfizer] PERIOD: [2010-ANNUAL ~ 2025-ANNUAL] [+] Accruals Ratio: -2.1% (OCF > NI, excellent cash generation) [+] Cash Conversion: 161% (> 80% = strong, < 50% = weak) [+] FCF Conversion: 132% (> 80% = excellent quality) Metric Value -------------------------- Avg Accruals Ratio -2.1% Avg Cash Conversion 161% Avg FCF Conversion 132% Cash Conv Stability 50.5% Period Net Income OCF FCF Accruals Cash Conv FCF Conv ---------------------------------------------------------------------- 2010 ANNUAL 8.26B 11.45B 9.94B -1.6% 138.8% 120.4% 2011 ANNUAL 10.01B 20.24B 18.36B -5.4% 202.3% 183.5% 2012 ANNUAL 14.57B 16.75B 15.33B -1.2% 115.0% 105.2% 2013 ANNUAL 22.00B 17.68B 16.22B 2.5% 80.4% 73.7% 2014 ANNUAL 9.13B 17.08B 15.50B -4.7% 187.0% 169.7% 2015 ANNUAL 6.96B 14.69B 13.19B -4.6% 211.1% 189.6% 2016 ANNUAL 7.21B 16.19B 14.19B -5.2% 224.5% 196.7% 2017 ANNUAL 21.31B 16.80B 14.59B 2.6% 78.9% 68.5% 2018 ANNUAL 11.15B 15.83B 13.69B -2.9% 141.9% 122.8% 2019 ANNUAL 16.02B 12.59B 10.54B 2.1% 78.6% 65.8% 2020 ANNUAL 9.16B 14.40B 12.18B -3.4% 157.3% 133.0% 2021 ANNUAL 21.98B 32.58B 29.87B -5.8% 148.2% 135.9% 2022 ANNUAL 31.37B 29.27B 26.03B 1.1% 93.3% 83.0% 2023 ANNUAL 2.12B 8.70B 4.79B -2.9% 410.6% 226.2% 2024 ANNUAL 8.03B 12.74B 9.84B -2.2% 158.7% 122.5% 2025 ANNUAL 7.77B 11.70B 9.07B -1.9% 150.6% 116.8%
audit earning-quality
EARNING QUALITY
TICKER: [US.PFE - Pfizer]
PERIOD: [2010-ANNUAL ~ 2025-ANNUAL]
[+] Accruals Ratio: -2.1% (OCF > NI, excellent cash generation)[+] Cash Conversion: 161% (> 80% = strong, < 50% = weak)[+] FCF Conversion: 132% (> 80% = excellent quality)
Metric Value--------------------------Avg Accruals Ratio -2.1%Avg Cash Conversion 161%Avg FCF Conversion 132%Cash Conv Stability 50.5%
Period Net Income OCF FCF Accruals Cash Conv FCF Conv----------------------------------------------------------------------2010 ANNUAL 8.26B 11.45B 9.94B -1.6% 138.8% 120.4%2011 ANNUAL 10.01B 20.24B 18.36B -5.4% 202.3% 183.5%2012 ANNUAL 14.57B 16.75B 15.33B -1.2% 115.0% 105.2%2013 ANNUAL 22.00B 17.68B 16.22B 2.5% 80.4% 73.7%2014 ANNUAL 9.13B 17.08B 15.50B -4.7% 187.0% 169.7%2015 ANNUAL 6.96B 14.69B 13.19B -4.6% 211.1% 189.6%2016 ANNUAL 7.21B 16.19B 14.19B -5.2% 224.5% 196.7%2017 ANNUAL 21.31B 16.80B 14.59B 2.6% 78.9% 68.5%2018 ANNUAL 11.15B 15.83B 13.69B -2.9% 141.9% 122.8%2019 ANNUAL 16.02B 12.59B 10.54B 2.1% 78.6% 65.8%2020 ANNUAL 9.16B 14.40B 12.18B -3.4% 157.3% 133.0%2021 ANNUAL 21.98B 32.58B 29.87B -5.8% 148.2% 135.9%2022 ANNUAL 31.37B 29.27B 26.03B 1.1% 93.3% 83.0%2023 ANNUAL 2.12B 8.70B 4.79B -2.9% 410.6% 226.2%2024 ANNUAL 8.03B 12.74B 9.84B -2.2% 158.7% 122.5%2025 ANNUAL 7.77B 11.70B 9.07B -1.9% 150.6% 116.8%